Omega Therapeutics, Inc. (OMGA) - Company Total Revenue
Omega Therapeutics relies on international epigenetics patents for long-term earnings. The company minimizes risks by regulating gene activity in the treatment of oncology and inflammation. The company's consolidated sales demonstrate revenue dynamics, where the value of the indicator is 0.01. However, potential liquidity shortages and delays in clinical trials of the mRNA platform remain key negative factors.
Comprehensive metric breakdowns and analytics for omegatherapeutics.com (OMGA)
- share price and expert price forecast:
- market capitalization indicators:
- book value of equity indicators:
- company liabilities and liquidity data:
Aggregate Debt to Equity Omega Therapeutics|OMGA - Long-Term Debt to Capital|Current Liabilities to Capital Omega Therapeutics|OMGA - Company Total Debt|Debts to Book Capitalization Omega Therapeutics Corp|OMGA - Company Long-Term Liabilities|Amount of Current Liabilities Omega Therapeutics|Interim Coverage Ratio omegatherapeutics.com
- earnings and valuation multiples indicators:
OMGA - Net Profit|Future Profit Omega Therapeutics|OMGA - Price to Earnings Ratio|Market Cap to Projected Earnings Omega Therapeutics Inc|OMGA - Price/Earnings to Growth Ratio|Company Value to EBITDA Omega|OMGA - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Omega Therapeutics|OMGA - Net earnings per share (EPS TTM)|Net earnings per share growth for the trailing year omegatherapeutics.com|OMGA - Earnings growth in current year|Earnings growth forecast for next year Omega Therapeutics
- company sales and revenue statistics:
General company analysis:OMGA, Omega Therapeutics, Inc.
For Omega Therapeutics (OMGA), which possesses an exclusive staff of epigenomic programming specialists, revenue serves as an indicator of the commercialization of its unique R&D competencies. By analyzing the company's absolute sales, an investor can track the daily cash inflow from counterparties, allowing for an assessment of current liquidity and the mitigation of cash gap risks without mistaking one-time payments for a sustainable long-term trend.
Competing companies
Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|SGMO (Sangamo Therapeutics) - Company Sales Volume|NAUT: Revenue and Sales Volume|Company Sales Volume MGX|DTIL (precisionbiosciences.com) - Revenue and Sales Volume|Company Sales Volume GBIO (Generation Bio Co.)|Company Revenue Boundless Bio (BOLD)|Exicure - Company Sales Volume|Revenue and Sales Volume IMNN (imunon.com)|Company Gross Revenue Phio Pharmaceuticals (PHIO)|MBIO: Company Sales|Company Sales Revenue RNAZ (transcodetherapeutics.com)|Bionano Genomics, Inc. (BNGO) - Company Revenue|APDN - Company Gross Revenue|Company Sales BLUE|Revenue and Sales Volume immunoprecise.com|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales
